The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.50
Bid: 15.00
Ask: 16.00
Change: -2.50 (-13.89%)
Spread: 1.00 (6.667%)
Open: 15.50
High: 16.50
Low: 15.25
Prev. Close: 18.00
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Angus Energy exceeds monthly production targets

Wed, 12th Oct 2022 14:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Angus Energy PLC - oil and gas development company focused on UK assets - Says that hourly throughput rates through its process plant now exceeds its October target production rate of 6 million standard cubic feet per day with well pressures holding in the high forties. Condensate production has stabilised at or around 120 barrels per day. Says side-track planning progresses with an adjustment to spud date to October 24 to 26 from October 20, 2022, in order to accommodate a potential supply chain issue.

----------

Canadian Overseas Petroleum Ltd - Calgary, Canada-based oil and gas company operating in Nigeria and US state of Wyoming - Receives gas flare approval for its operated 85% WI Barron Flats Shannon Unit, from Wyoming Oil & Gas Conservation Commission. "This is a great result as it will allow the company to manage increased gas production with associated high working pressures as the miscible bank moves in the injection patterns. In addition, our oil production from the Shannon Unit will increase as production rates have been restricted in certain wells due to these issues," says Chief Executive Arthur Millholland.

----------

Kistos PLC - London-based energy industry investor with licenses in the Netherlands - Says High Court of Justice of England & Wales approves cancellation of bonus shares issued on Monday and the credit of EUR50.0 million to the company's share premium account. Expects the court order approving the capital reduction, and a statement of capital approved by the court, to be filed with the Registrar of Companies no later than October 22.

----------

UniVision Engineering Ltd - Hong Kong-based CCTV and surveillance system company - Enters loan agreement with Webright Ventures Ltd to borrow GBP1.4 million. Says the loan will be unsecured, will have a period of three months and an interest rate of 8% per year. Around half the loan will be used as funds set aside ahead of the hearing of the winding-up petition against UniVision, which was announced back in January, and is due to be heard in court in Hong Kong on October 18. Adds that it is still working with its auditors to complete its audit and publish its annual report, after which the company's shares are expected to begin trading on London's AIM.

----------

Angle PLC - Surrey, England-based medical diagnostics company - Signs distribution agreement with Promedeus SRO to enable and support the roll out of the US Food & Drug Administration cleared and CE marked Parsortix PC1 system across the Czech Republic for its intended use in metastatic breast cancer. Says Promedeus, a part of the Vendeavour Group, a Private Equity fund with a focus on healthcare, has considerable expertise in distributing a range of advanced medical equipment into the Czech hospital and primary care markets with a track record for delivering high quality physician education and customer care. "We are pleased to enter into this agreement with Promedeus and are encouraged by the efforts that the Promedeus team has already made to understand the benefits that the Parsortix system can bring to their oncology focused customer base. They have a strong track record and local knowledge which can help support the development of a new market for Parsortix," says Founder & Chief Executive Andrew Newland.

----------

By Sophie Rose; sophierose@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
28 Feb 2019 13:30

Angle Enrolls First Patients In Ovarian Cancer Study

LONDON (Alliance News) - Angle PLC on Thursday said it has enrolled the first patients in an ovarian cancer verification study, after receiving ethics approval.The study will be divided a a

Read more
25 Feb 2019 10:51

Angle client demonstrates new use for 'Parsortix' system

(Sharecast News) - Liquid biopsy company Angle said on Monday that one of its leading customers, the Disseminated Cancer Cell Network (DCCNet) in Duesseldorf, has published new results in a peer-reviewed journal of work done to harvest circulating tumor cells (CTCs) from diagnostic leukapheresis (DLA) samples.

Read more
11 Feb 2019 11:35

Angle's 'Parsortix' used in new groundbreaking cancer research

(Sharecast News) - Liquid biopsy company Angle announced on Monday that its 'Parsortix' system had been utilised in further "groundbreaking" cancer research into CTC clusters, reportedly demonstrating that the patient's own immune cells (neutrophils) could actively help the process of metastasis by which the cancer spread.

Read more
31 Jan 2019 12:04

Angle Reports Widened Interim Loss On Higher Operating Costs

LONDON (Alliance News) - Angle PLC on Thursday reported a widened interim loss on an increase operating costs.In the six months to October 31, the tumour cell researcher said its pretax to

Read more
24 Jan 2019 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 25 January BonmarcheTrading Statement AG BarrTrading GroupQ3 Smaller

Read more
10 Jan 2019 17:05

Angle Shares Jump As Parsortix System Used In New Cancer Treatment

LONDON (Alliance News) - Angle PLC shares spiked late Thursday afternoon after the company said its Partsortix system will be used in "ground-breaking" new cancer research.Shares

Read more
5 Nov 2018 12:11

ANGLE To Acquire Remaining Stake In US Subsidiary For GBP467,500 (ALLISS)

LONDON (Alliance News) - Liquid biopsy company ANGLE PLC said on Monday it has agreed to acquire the remaining shares in US subsidiary ANGLE North America Inc it does not own from Parsotix Georgi

Read more
1 Nov 2018 14:09

Angle Appoints Cancer Diagnostic Firm Chief As Non-Executive Director

LONDON (Alliance News) - Biopsy company Angle PLC said Thursday it has appointed the President of Euronext-listed cancer diagnostics firm MDxHealth to its board.Jan Groen joins the board of

Read more
29 Oct 2018 11:27

Angle Pilot Study Shows Promise Of Parsortix In Prenatal Testing

LONDON (Alliance News) - Liquid biopsy company Angle PLC on Monday said it has received positive results from a study examining the use of its Parsortix system in prenatal testing.Shares in

Read more
29 Oct 2018 11:08

Angle sees 'highly encouraging' results from prenatal testing

(Sharecast News) - Medical diagnostics outfit Angle is talking to "several interested parties" to commercialise its testing device after a "highly encouraging" trial indicated it could be adapted as a non-invasive prenatal test.

Read more
25 Oct 2018 12:55

Angle Nearing Completion Of Patient Enrolment Breast Cancer Study

LONDON (Alliance News) - Liquid biopsy firm Angle PLC said it is making good progress on recruiting patients for its ANG-002 clinical study.The study is focusing on a treatment for breast a

Read more
25 Oct 2018 08:52

Angle makes 'good progress' with ANG-002 patient enrolment

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that patient enrolment for its ANG-002 FDA clinical study for metastatic breast cancer had continued to make good progress.

Read more
23 Oct 2018 15:59

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 24 OctoberIndigovisionBeeks FinancialReddePhoto-Me 25 & Smart 26 29 30

Read more
28 Aug 2018 14:17

Angle's Parsortix System Able To Identify Tumour Cells In Glioblastoma

LONDON (Alliance News) - Angle PLC on Tuesday said researchers at the Cancer Metastasis Laboratory, located at the University of Basel, have provided evidence of circulating tumour cell clusters a

Read more
14 May 2018 12:17

ANGLE Appoints Urological Surgeon Greg Shaw As Scientific Advisor

LONDON (Alliance News) - ANGLE PLC said Monday it appointed urological surgeon, Greg Shaw, as a scientific advisor.The liquid biopsy company appointed the prostate cancer UK National Health

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.